Wealth Plan Partners, LLC Abb Vie Inc. Transaction History

Wealth Plan Partners, LLC

$745 Billion
Q3 2024

A detailed history of Wealth Plan Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Plan Partners, LLC holds 34,423 shares of ABBV stock, worth $6.17 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

34,423

Previous 41,623 17.3%

Holding current value

$6.17 Million

Previous $7.14 Billion 4.78%

% of portfolio

0.91%

Previous 0.77%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$163.84 - $199.33 $1.18 Million - $1.44 Million	-7,200 Reduced 17.3%	34,423 $6.8 Billion
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $172,126 - $201,005	-1,112 Reduced 2.6%	41,623 $7.14 Billion
Q1 2024 May 07, 2024	SELL	$159.82 - $182.1 $2.29 Million - $2.61 Million	-14,306 Reduced 25.08%	42,735 $7.78 Billion
Q4 2023 Jan 05, 2024	BUY	$137.6 - $154.97 $33,849 - $38,122	246 Added 0.43%	57,041 $8.84 Billion
Q3 2023 Nov 01, 2023	BUY	$133.59 - $154.65 $3.58 Million - $4.15 Million	26,833 Added 89.56%	56,795 $8.47 Billion
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $3.91 Million - $4.87 Million	-29,516 Reduced 49.63%	29,962 $4.04 Billion
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $8.51 Million - $9.8 Million	-58,850 Reduced 49.73%	59,478 $9.48 Billion
Q4 2022 Feb 16, 2023	BUY	$138.31 - $165.87 $15.5 Million - $18.6 Million	112,278 Added 1855.83%	118,328 $18.1 Billion
Q1 2022 May 03, 2022	BUY	$131.98 - $163.75 $20,192 - $25,053	153 Added 2.59%	6,050 $889,000
Q4 2021 Feb 01, 2022	SELL	$107.43 - $135.93 $25,675 - $32,487	-239 Reduced 3.9%	5,897 $807,000
Q3 2021 Dec 09, 2021	BUY	$106.4 - $120.78 $30,004 - $34,059	282 Added 4.82%	6,136 $661,000
Q2 2021 Aug 19, 2021	BUY	$105.21 - $117.21 $46,502 - $51,806	442 Added 8.17%	5,854 $665,000
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $37,032 - $40,768	-362 Reduced 6.27%	5,412 $616,000
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $2,334 - $3,151	29 Added 0.5%	5,774 $626,000
Q3 2020 Dec 18, 2020	BUY	$85.91 - $100.83 $10,652 - $12,502	124 Added 2.21%	5,745 $560,000
Q2 2020 Aug 19, 2020	BUY	$73.37 - $98.18 $5,135 - $6,872	70 Added 1.26%	5,621 $532,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $126,936 - $192,450	1,968 Added 54.93%	5,551 $499,000
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $18,321 - $22,923	254 Added 7.63%	3,583 $350,000
Q3 2019 Nov 15, 2019	SELL	$62.98 - $75.72 $197,001 - $236,852	-3,128 Reduced 48.44%	3,329 $288,000
Q2 2019 Aug 19, 2019	SELL	$65.7 - $83.98 $386,578 - $494,138	-5,884 Reduced 47.68%	6,457 $420,000
Q1 2019 May 16, 2019	SELL	$77.14 - $90.79 $40,575 - $47,755	-526 Reduced 4.09%	12,341 $972,000
Q4 2018 Feb 20, 2019	BUY	$77.85 - $96.01 $554,681 - $684,071	7,125 Added 124.09%	12,867 $1.04 Million
Q3 2018 Nov 21, 2018	BUY	$88.91 - $98.84 $97,978 - $108,921	1,102 Added 23.75%	5,742 $506,000
Q2 2018 Aug 16, 2018	BUY	$89.78 - $106.23 $38,605 - $45,678	430 Added 10.21%	4,640 $430,000
Q1 2018 May 16, 2018	BUY	$92.01 - $123.21 $387,362 - $518,714	4,210 New	4,210 $399,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Plan Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Plan Partners, LLC with notifications on news.

Account

Wealth Plan Partners, LLC Abb Vie Inc. Transaction History